Lansforsakringar Fondforvaltning Ab (Publ) Bio Techne Corp Call Options Transaction History
Lansforsakringar Fondforvaltning Ab (Publ)
- $15.9 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding TECH
# of Institutions
629Shares Held
157MCall Options Held
90KPut Options Held
14.2K-
Vanguard Group Inc Valley Forge, PA18.5MShares$894 Million0.02% of portfolio
-
Black Rock Inc. New York, NY15MShares$723 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.4MShares$549 Million0.08% of portfolio
-
State Street Corp Boston, MA6.53MShares$315 Million0.02% of portfolio
-
Morgan Stanley New York, NY5.72MShares$276 Million0.02% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $1.89B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...